ClinicalTrials.gov
public full text
Public Domain
A Trial of Lu AG13909 in Participants With Congenital Adrenal Hyperplasia
This trial will evaluate the effects of different doses of Lu AG13909 in adult participants with congenital adrenal hyperplasia, also called CAH. CAH is a rare genetic disorder that affects a person's ability to produce certain hormones. The main goals of this trial are to learn about the safety and tolerability of Lu AG13909, how Lu AG13909 behaves in the body, and how the body responds to Lu AG13909.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Die organische Chemie in ihrer Anwendung auf Agricultur und Physiologie#1347574
- Shanghai Clinical Cohort - Adrenal Disease#873153
- Genetic Developmental and Epileptic Encephalopathy Natural History Study for Clinical Trial Readiness#839729
- Effect of Genes on Rosuvastatin Therapy for Hyperlipidemia#1369181
- Subclassification of the Syndrome of Inappropriate ADH Secretion#1292858
Record · ID 1350778
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive